The mGluR5 antibody was initially detected in 2011 serum samples from limbic encephalitis and Hodgkin’s lymphoma patients.[7] Furthermore, it has been reported that over half of the patients with anti-mGluR5 encephalitis in Western countries exhibit a correlation with tumors (primarily Hodgkin’s disease). This evidence concerns the gene GRM5 and encephalitis.